文献速递糖尿病

餐前胰岛素注射降低1型糖尿病餐后血糖并增加心肌微血管血流

Premeal insulin administration lowers postprandial blood glucose and increases myocardial microvascular blood flow in people with type 1 diabetes: a randomised, crossover clinical trial.
PubMed 文献 · Diabetologia · 2026-07-11

这项随机交叉临床试验纳入18名18-35岁、BMI<30 kg/m2的1型糖尿病患者和18名匹配对照,比较餐前15分钟与餐后15分钟注射胰岛素的影响。结果显示餐前注射组餐后血糖曲线下面积显著更低(p=0.015),心肌微血管血流速度(p=0.031)和心肌微血管血流量(p=0.044)显著增加。结论提示适时餐前胰岛素可改善餐后血糖及心肌微血管灌注。

要点

  • 餐前15分钟注射胰岛素较餐后注射显著降低1型糖尿病餐后血糖曲线下面积(p=0.015)。
  • 餐前胰岛素注射使心肌微血管血流速度(p=0.031)和心肌微血管血流量(p=0.044)显著增加。
  • 其他方案中未见心肌微血管血流变化,生命体征变化在各方案间相似。

核心结论

  • 适时餐前注射胰岛素可降低1型糖尿病患者餐后血糖并增加心肌微血管血流量。

研究设计与样本

  • 采用1:1随机交叉设计,1型糖尿病受试者在两个方案中分别于餐前15分钟或餐后15分钟注射餐时胰岛素。
  • 纳入18名18-35岁、BMI<30 kg/m2的1型糖尿病患者,以及18名年龄、性别和BMI匹配的对照者完成单次无外源胰岛素的研究。
  • 主要结局为各方案内心肌微血管血流量的变化,结局评估人员对分组设盲。

主要发现

  • 1型糖尿病患者餐后胰岛素方案的血糖曲线下面积显著大于餐前胰岛素方案(p=0.015)。
  • 餐前胰岛素注射使1型糖尿病患者心肌微血管血流速度显著增加(p=0.031),并因此导致心肌微血管血流量更大(p=0.044)。
  • 其他方案内未见心肌微血管血流量变化,各方案间生命体征变化相似。

临床怎么用

  • 对18-35岁、BMI<30 kg/m2的1型糖尿病患者,餐前15分钟注射餐时胰岛素可能有助于降低餐后血糖并改善心肌微血管灌注。

局限性

  • 研究样本量较小,仅纳入18名1型糖尿病患者和18名对照。
  • 研究期限短,仅评估餐后2小时内的急性效应,长期临床获益不明确。
  • 作者指出需进一步研究确定这些变化的潜在病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to evaluate whether prandial insulin timing affects vascular function in people with type 1 diabetes. Our hypothesis was that premeal insulin administration would lead to greater myocardial microvascular blood flow (MBF) via blunting postprandial hyperglycaemia. METHODS: People with type 1 diabetes between 18 and 35 years of age with BMI <30 kg/m2 underwent two protocols with a 1:1 randomised crossover design wherein prandial insulin was injected either 15 min before or 15 min after meal intake began. To provide a physiological comparison, age-, sex- and BMI-matched control participants completed one study where they consumed the same meal but received no exogenous insulin. Glucose, insulin, vascular function (including ultrasound measures of myocardial and skeletal muscle microvascular perfusion, aortic stiffness, brachial artery endothelial function) and biomarkers of systemic inflammation and endothelial dysfunction were assessed at baseline and then 2 h after meal ingestion within each protocol. The primary outcome was change in myocardial MBF within each protocol. Study personnel assessing outcomes were masked to group assignment. RESULTS: Eighteen people with type 1 diabetes and 18 matched control participants were analysed within each protocol. Glucose area under the curve was significantly greater (p=0.015) in the postmeal insulin study compared with the premeal insulin study in participants with type 1 diabetes. Myocardial microvascular flow velocity significantly increased (p=0.031) with premeal insulin administration in people with type 1 diabetes and this consequently led to greater myocardial MBF (p=0.044). There were no changes in myocardial MBF within the other protocols. Changes in vital signs were similar between all protocols. CONCLUSIONS/INTERPRETATION: Appropriately timed premeal insulin led to lower postprandial blood glucose along with increased myocardial MBF in people with type 1 diabetes. Further work is needed to determine the underlying aetiology of these changes. TRIAL REGISTRATION: ClinicalTrials.gov NCT04730882.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Horton WB, Anderson KC, Love KM, et al. Premeal insulin administration lowers postprandial blood glucose and increases myocardial microvascular blood flow in people with type 1 diabetes: a randomised, crossover clinical trial. Diabetologia. 2026. PMID: 42432283. doi:10.1007/s00125-026-06806-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。